Kenya's Ministry of Health has approved the rollout of lenacapavir, an injectable HIV prevention drug administered twice yearly, following a comprehensive scientific assessment. This makes Kenya one of the first African countries to recommend its registration, aligning with global public health guidance.

• The drug is administered only twice a year, offering an alternative to daily oral medication.
• Aden Duale, cabinet secretary in the Ministry of Health, announced the approval.
• New HIV infections in Kenya rose by 19 percent, from 16,752 in 2023 to 19,991 in 2024.